Berenberg and Deutsche Bank maintain 'Buy' ratings for Diageo and Qiagen NV

Berenberg has maintained a "Buy" rating for Diageo with a price target of 2223 pence following the company's financial results. While revenue aligned with consensus estimates and operating profit slightly exceeded expectations, the company faces ongoing pressure in North America. Conversely, markets in Latin America, Africa, and Europe provided expected support.

Separately, Deutsche Bank Research has raised its price target for Qiagen NV from $43 to $47, maintaining a "Buy" rating after second-quarter results. Analyst Jan Koch noted an operational improvement for the diagnostics specialist, suggesting that a lower-than-expected forecast for the third quarter reflects management's cautious stance rather than a decline in core business operations.